Shares of Ajanta Pharma rose 2.09% to Rs 2,824.90 in Tuesday's session, driven by bullish investor sentiment. The stock is among the top gainers on the Nifty Midcap 150 index.
On the financial front, the consolidated revenue for Ajanta Pharma showed consistent growth. Quarterly revenue increased from Rs 1,144.92 Crore in June 2024 to Rs 1,302.65 Crore in June 2025. Net profit also rose from Rs 245.77 Crore to Rs 255.34 Crore during the same period. The EPS increased from Rs 19.54 to Rs 20.44.
The annual consolidated revenue grew from Rs 4,208.71 Crore in 2024 to Rs 4,648.10 Crore in 2025. Annual net profit increased from Rs 816.17 Crore to Rs 920.39 Crore, and EPS grew from Rs 64.82 to Rs 73.56.
Here is a detailed look at Ajanta Pharma's financial performance:
| Heading | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 1,144.92 Crore | Rs 1,186.64 Crore | Rs 1,146.13 Crore | Rs 1,170.41 Crore | Rs 1,302.65 Crore |
| Net Profit | Rs 245.77 Crore | Rs 216.48 Crore | Rs 232.88 Crore | Rs 225.26 Crore | Rs 255.34 Crore |
| EPS | 19.54 | 17.27 | 18.60 | 18.00 | 20.44 |
| Heading | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 2,889.69 Crore | Rs 3,340.99 Crore | Rs 3,742.64 Crore | Rs 4,208.71 Crore | Rs 4,648.10 Crore |
| Net Profit | Rs 653.87 Crore | Rs 712.68 Crore | Rs 587.98 Crore | Rs 816.17 Crore | Rs 920.39 Crore |
| EPS | 75.09 | 82.45 | 45.89 | 64.82 | 73.56 |
| BVPS | 344.52 | 380.24 | 268.14 | 282.34 | 302.38 |
| ROE | 21.82 | 21.83 | 17.35 | 22.87 | 24.28 |
| Debt to Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Basic EPS (Rs.) | 73.56 | 64.82 | 45.89 | 82.45 | 75.09 |
| Diluted Eps (Rs.) | 73.53 | 64.77 | 45.89 | 82.45 | 75.09 |
| Book Value [Excl. Reval Reserve]/Share (Rs.) | 302.38 | 282.34 | 268.14 | 380.24 | 344.52 |
| Dividend/Share (Rs.) | 28.00 | 51.00 | 7.00 | 9.50 | 9.50 |
| Face Value | 2 | 2 | 2 | 2 | 2 |
The company's stock split history includes splits announced on January 28, 2015 (old FV of 5, new FV of 2, ex-split date of March 20, 2015) and April 26, 2012 (old FV of 10, new FV of 5, ex-split date of August 9, 2012).
As of today, Moneycontrol analysis indicates a very bullish sentiment for Ajanta Pharma.
Shares of Ajanta Pharma rose 2.09% to Rs 2,824.90, driven by bullish investor sentiment.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
